The state of knowledge regarding pertussis amongst young adults
Keywordswhooping cough, Bordetella pertussis, infectious disease
Pertussis remains a serious health problem to this day. Even though a successful vaccine campaign reduced the morbidity rate in most countries, it still is a present and concerning disease. The sickness is especially dangerous to infants and young children, as it may result in serious health complications, and even death. The aim of this study was to determine how much do young adults know about this condition, and how often does pertussis occur within this population, as well as within its family members. Materials and methods: data was collected with use of an authorial survey, which was handed around a group of 201 freshmen medical students in contact, in April 2022. Results: Most of the students possess basic knowledge regarding aetiology, routes of transmission and symptoms of pertussis, but lack information about the vaccines, treatment, course of the disease and specific at-risk groups. Some students were diagnosed with the condition in the past, and some have a family member diagnosed with it sometime. Conclusion: Young adults have basic knowledge regarding pertussis, but they should be educated about some aspects of this sickness, with use of social campaigns or advertisements. Only some of the people are affected by pertussis during their life, as the disease is relatively rare in developed countries. A possibility of getting a booster shot of pertussis vaccine should be touted.
Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev. 2016; 29(3): 449-486. https://doi.org/10.1128/CMR.00083-15
Bernstein H, McNally VV. Pertussis Vaccination-A Critical Priority for Us All. JAMA Netw Open. 2021; 4(8): e2119365. https://doi.org/10.1001/jamanetworkopen.2021.19365
Esposito S, Principi N. Prevention of pertussis: An unresolved problem. Hum Vaccin Immunother. 2018; 14(10): 2452-2459. https://doi.org/10.1080/21645515.2018.1480298
Podavalenko AP, Nessonova TD, Zadorozhna VI, et al. EPIDEMIOLOGICAL ANALIYSIS OF PERTUSSIS MORBIDITY IN UKRAINE. Wiad Lek. 2021; 74(7): 1628-1633.
Thommes E, Wu J, Xiao Y, et al. Revisiting the epidemiology of pertussis in Canada, 1924-2015: a literature review, evidence synthesis, and modeling study. BMC Public Health. 2020; 20(1): 1749. https://doi.org/10.1186/s12889-020-09854-4
European Centre for Disease Prevention and Control. Pertussis In: ECDC. Annual epidemiological report for 2018. Stockholm: ECDC; 2020. Accessed 22 Jul 2022
Özer S, Oğuz VA. Pediatric hospital healthcare workers and pertussis; a seroprevalence study. Turk J Pediatr. 2021; 63(3): 355-362. https://doi.org/10.24953/turkjped.2021.03.002
Tessier E, Campbell H, Ribeiro S, et al. Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019 [published correction appears in Euro Surveill. 2022 Jan;27(2):]. Euro Surveill. 2021; 26(12): 2000244. https://doi.org/10.2807/1560-7917.ES.2021.26.12.2000244
Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hall E., Wodi A.P., Hamborsky J., et al., eds. 14th ed. Washington, D.C. Public Health Foundation, 2021. Accessed 23 Jul 2022
Belcher T, Dubois V, Rivera-Millot A, et al. Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host. Virulence. 2021; 12(1): 2608-2632. https://doi.org/10.1080/21505594.2021.1980987
Trainor EA, Nicholson TL, Merkel TJ. Bordetella pertussis transmission. Pathog Dis. 2015; 73(8): ftv068. https://doi.org/10.1093/femspd/ftv068
Ather B, Mirza TM, Edemekong PF. Airborne Precautions. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 22, 2022.
Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr Opin Immunol. 2019; 59: 72-78. https://doi.org/10.1016/j.coi.2019.03.006
Versteegen P, Bonačić Marinović AA, et al. Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy. Vaccines (Basel). 2022; 10(5): 693. https://doi.org/10.3390/vaccines10050693
Nguyen KH, Srivastav A, Lindley MC, et al. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination. Am J Prev Med. 2022; 62(3): 367-376. https://doi.org/10.1016/j.amepre.2021.08.015
Phadke VK, Bednarczyk RA, Salmon DA, et al. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA. 2016; 315(11): 1149-58. https://doi.org/10.1001/jama.2016.1353
Kachoria AG, Mubarak MY, Singh AK, et al. The association of religion with maternal and child health outcomes in South Asian countries. PLoS One. 2022; 17(7): e0271165. https://doi.org/10.1371/journal.pone.0271165
Centers for Disease Control and Prevention (CDC) (2017) Vaccination coverage among Adults in the United States, National Health Interview Survey. https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2017.html. Accessed 25 Jul 2022
Choi JH, Correia de Sousa J, Fletcher M, et al. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging Clin Exp Res. 2022; 34(1): 1-8. https://doi.org/10.1007/s40520-021-02018-3
Jenkins VA, Savic M, Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccin Immunother. 2020; 16(11): 2609-2617. https://doi.org/10.1080/21645515.2020.1738168
Xu J, Liu S, Liu Q, et al. The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(16): e15281. https://doi.org/10.1097/MD.0000000000015281
Kandeil W, Atanasov P, Avramioti D, et al. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019; 18(5): 439-455. https://doi.org/10.1080/14760584.2019.1588727
Havers FP, Moro PL, Hunter P, et al. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019. MMWR Morb Mortal Wkly Rep 2020; 69: 77–83.
Maltezou HC, Rahiotis C, Tseroni M, et al. Attitudes toward Vaccinations and Vaccination Coverage Rates among Dental Students in Greece. Int J Environ Res Public Health. 2022; 19(5): 2879. https://doi.org/10.3390/ijerph19052879
Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee Opinion No. 718. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017; 130: e153–7.
Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis. 2021; 224(12 Suppl 2): S310-S320. https://doi.org/10.1093/infdis/jiaa469
Skoff TH, Blain AE, Watt J, et al. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation. Clin Infect Dis. 2017; 65(12): 1977-1983. https://doi.org/10.1093/cid/cix724
Vygen-Bonnet S, Hellenbrand W, Garbe E, et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review. BMC Infect Dis. 2020; 20(1): 136. https://doi.org/10.1186/s12879-020-4824-3
Di Camillo C, Vittucci AC, Antilici L, et al. Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital. Hum Vaccin Immunother. 2021; 17(3): 705-713. https://doi.org/10.1080/21645515.2020.1791617
Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Signs and Symptoms. https://www.cdc.gov/pertussis/about/signs-symptoms.html. Accessed 25 Jul 2022.
Macina D, Evans KE. Pertussis in Individuals with Co-morbidities: A Systematic Review. Infect Dis Ther. 2021; 10(3): 1141-1170. https://doi.org/10.1007/s40121-021-00465-z
He F, Xia X, Nie D, et al. Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients. Diagn Microbiol Infect Dis. 2020; 98(4): 115199. https://doi.org/10.1016/j.diagmicrobio.2020.115199
de Greeff SC, van Buul LW, Westerhof A, et al. Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age. Vaccine. 2011; 29(46): 8275-8. https://doi.org/10.1016/j.vaccine.2011.08.112
Yeung KHT, Duclos P, Nelson EAS, et al. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017; 17(9): 974-980. https://doi.org/10.1016/S1473-3099(17)30390-0
Shi T, Wang L, Du S, et al. Mortality risk factors among hospitalized children with severe pertussis. BMC Infect Dis. 2021; 21(1): 1057. https://doi.org/10.1186/s12879-021-06732-1
Wang C, Zhang H, Zhang Y, et al. Analysis of clinical characteristics of severe pertussis in infants and children: a retrospective study. BMC Pediatr. 2021; 21(1): 65. https://doi.org/10.1186/s12887-021-02507-4
Viticchi G, Falsetti L, Baruffaldi R, et al. Acute carotid dissection in an adult caused by pertussis. J Stroke Cerebrovasc Dis. 2013; 22(8): e635-6. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.01.008
Monaco F, Barone M, Manfredi VG, et al. Pneumomediastinum as a complication of critical pertussis. Clin Respir J. 2016; 10(6): 772-776. https://doi.org/10.1111/crj.12285
Bal C, Baumgartner R, Gompelmann D, et al. Angioedema as a predominant symptom of Bordetella pertussis infection. BMJ Case Rep. 2021; 14(3): e239243. https://doi.org/10.1136/bcr-2020-239243
Matczak S, Levy C, Fortas C, et al. Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020. Euro Surveill. 2022; 27(25): 2100933. https://doi.org/10.2807/1560-7917.ES.2022.27.25.2100933
Tessier E, Campbell H, Ribeiro S, et al. Impact of the COVID-19 pandemic on Bordetella pertussis infections in England. BMC Public Health. 2022; 22(1): 405. https://doi.org/10.1186/s12889-022-12830-9
Oh SC, Park SM, Hur J, et al. Effectiveness of rapid multiplex polymerase chain reaction for early diagnosis and treatment of pertussis. J Microbiol Immunol Infect. 2021; 54(4): 687-692. https://doi.org/10.1016/j.jmii.2020.05.012
Center for Disease Control and Prevention. Pertussis Diagnosis Confirmation. https://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-confirmation.html. Accessed 02 Aug 2022.
Center for Disease Control and Prevention. For Clinicians: Pertussis Treatment. https://www.cdc.gov/pertussis/clinical/treatment.html. Accessed 02 Aug 2022.
Kow CS, Hasan SS. Macrolides for patients with COVID-19 and concurrent pertussis infection. Diagn Microbiol Infect Dis. 2021; 99(2): 115245. https://doi.org/10.1016/j.diagmicrobio.2020.115245
Fiasca F, Necozione S, Mattei A. Pertussis in Italy: how to protect the "unprotectable"? Hum Vaccin Immunother. 2021; 17(4): 1136-1141. https://doi.org/10.1080/21645515.2020.1806673
Center for Disease Control and Prevention. Fast Facts about Whooping Cough. https://www.cdc.gov/pertussis/fast-facts.html. Accessed 03 Aug 2022.
McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015; 135(2): 331-43. https://doi.org/10.1542/peds.2014-1729
How to Cite
Copyright (c) 2022 Bartosz Borowski, Zuzanna Kupisz, Patrycja Długosz, Małgorzata Kozioł
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 249
Number of citations: 0